▶주메뉴 바로가기

▶본문 바로가기

검색폼

THE INVESTOR

Market Now

Access Bio acquires patent for G6PD deficiency diagnosis technology

  • PUBLISHED :January 11, 2017 - 15:51
  • UPDATED :January 11, 2017 - 15:51
  • 폰트작게
  • 폰트크게
  • facebook
  • twitter
  • sms
  • print
[DISCLOSURE] Access Bio (950130) announced on Jan. 11 that it has acquired a patent in the US for an improved technology related to diagnosis of G6PD deficiency, a hereditary blood disease.

(theinvestor@heraldcorp.com)

  • facebook
  • twitter
  • sms
  • print

TOP NEWS